News

As per the terms of the agreement, Sapient Discovery is expected to apply its proprietary structural biology platform and expertise to determine the three-dimensional structures for targets of

Cytokine results of the dose-finding study in pregnant women at term gestation confirmed the efficacy and safety of its investigational product and suggested that the MVI may reduce

In 2006, Mr Grant began his tenure as Allergan’s corporate vice president and president. Prior to that he has served as acting chairman, president and CEO of Biolase

Teva’s product is sold as a generic version of Bayer HealthCare’s oral contraceptive YAZ, a progesterone and estrogen combination birth control pill. It works by preventing ovulation, thickening

Ulimorelin is entering Phase 3 development for the treatment of gastrointestinal dysmotility conditions in acute care settings. As per the agreement, Norgine is expected to make an upfront

Pieris said that the trial is designed to test PRS-050 in approximately 40 patients, who will receive the compound and then be monitored for safety and tolerability. The

Biocius and BlueSky said that the collaboration builds on an existing partnership and will improve drug discovery efficiency of the SIRT class of epigenetic modulating enzymes, which are

Capsugel claimed that its France facility Ploermel provides clinical trial and commercial pharmaceutical product manufacturing services to customers around the world. The FDA’s Pre-Approval and Good Manufacturing Practices

Takeda’s wholly-owned subsidiary Takeda San Diego has developed Nesina, a dipeptidyl peptidase-IV (DPP-4) inhibitor, which exhibits high selectivity for DPP-4 inhibition, and a once daily dosing of the